News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,672 Results
Type
Article (42023)
Company Profile (473)
Press Release (665176)
Section
Business (209158)
Career Advice (2038)
Deals (36028)
Drug Delivery (97)
Drug Development (83530)
Employer Resources (169)
FDA (16402)
Job Trends (15076)
News (353285)
Policy (33110)
Tag
Academia (2629)
Alliances (50888)
Alzheimer's disease (1340)
Approvals (16356)
Artificial intelligence (172)
Bankruptcy (363)
Best Places to Work (11815)
Biotechnology (355)
Breast cancer (209)
Cancer (1567)
Cardiovascular disease (130)
Career advice (1701)
CAR-T (111)
Cell therapy (332)
Clinical research (66797)
Collaboration (600)
Compensation (311)
COVID-19 (2616)
C-suite (140)
Data (1495)
Diabetes (193)
Diagnostics (6270)
Earnings (86630)
Employer resources (147)
Events (114111)
Executive appointments (493)
FDA (17191)
Funding (537)
Gene therapy (234)
GLP-1 (657)
Government (4439)
Healthcare (19115)
Infectious disease (2713)
Inflammatory bowel disease (121)
Interviews (313)
IPO (16695)
Job creations (3708)
Job search strategy (1450)
Layoffs (453)
Legal (7977)
Lung cancer (230)
Manufacturing (222)
Medical device (13397)
Medtech (13402)
Mergers & acquisitions (19589)
Metabolic disorders (521)
Neuroscience (1727)
NextGen: Class of 2025 (6754)
Non-profit (4556)
Northern California (1890)
Obesity (297)
Opinion (206)
Patents (134)
People (58159)
Phase I (20969)
Phase II (29463)
Phase III (21797)
Pipeline (625)
Postmarket research (2611)
Preclinical (8963)
Radiopharmaceuticals (256)
Rare diseases (304)
Real estate (6027)
Regulatory (22302)
Research institute (2424)
Resumes & cover letters (352)
Southern California (1649)
Startups (3753)
United States (17129)
Vaccines (598)
Weight loss (211)
Date
Today (128)
Last 7 days (409)
Last 30 days (2022)
Last 365 days (35971)
2025 (1769)
2024 (36383)
2023 (41070)
2022 (52330)
2021 (56799)
2020 (54988)
2019 (47555)
2018 (35786)
2017 (33087)
2016 (32425)
2015 (38484)
2014 (32250)
2013 (27212)
2012 (29364)
2011 (30012)
2010 (28190)
Location
Africa (736)
Arizona (211)
Asia (38884)
Australia (6460)
California (4358)
Canada (1565)
China (369)
Colorado (194)
Connecticut (216)
Europe (84779)
Florida (609)
Georgia (147)
Illinois (430)
Indiana (245)
Maryland (710)
Massachusetts (3424)
Michigan (186)
Minnesota (323)
New Jersey (1208)
New York (1226)
North Carolina (846)
Northern California (1890)
Ohio (156)
Pennsylvania (1012)
South America (1111)
Southern California (1649)
Texas (634)
Utah (121)
Washington State (443)
707,672 Results for "y mabs therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Y-mAbs Provides Strategic Business Update and 2025 Priorities
January 13, 2025
·
10 min read
Press Releases
Y-mAbs Appoints Experienced Commercial Leader as Head of DANYELZA Business Unit
January 13, 2025
·
4 min read
Press Releases
Correcting & Replacing – Y-mAbs Provides Strategic Business Update and 2025 Priorities
January 13, 2025
·
11 min read
Business
Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Development Officer
Y-mAbs Therapeutics, Inc. announced the appointment of Norman LaFrance, M.D. as Chief Development Officer.
June 5, 2024
·
7 min read
Business
Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer
Y-mAbs Therapeutics, Inc. today announced that Chief Financial Officer, Bo Kruse, has notified the Company of his resignation.
March 14, 2024
·
6 min read
Pharm Country
Y-mAbs to Present at 2024 ASCO Annual Meeting
Y-mAbs Therapeutics, Inc. announced the acceptance of four abstracts at the 2024 American Society of Clinical Oncology Annual Meeting, taking place May 31 – June 4, 2024 in Chicago, IL.
April 25, 2024
·
8 min read
Press Releases
Y-mAbs to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 23, 2024
·
2 min read
Press Releases
Y-mAbs to Participate at Citi’s 2024 Global Healthcare Conference
November 27, 2024
·
5 min read
Pharm Country
Y-mAbs Announces Preclinical GD2-SADA Data to be Presented at 2024 SNMMI Annual Meeting
Y-mAbs Therapeutics, Inc today announced that preclinical GD2-SADA data will be presented at the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2024 Annual Meeting taking place June 8 – 11, 2024, in Toronto.
June 7, 2024
·
7 min read
Business
Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of cancer, reported financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
15 min read
1 of 70,768
Next
